Stay updated on Dasiglucagon Clinical Trial in Congenital Hyperinsulinism
Sign up to get notified when there's something new on the Dasiglucagon Clinical Trial in Congenital Hyperinsulinism page.

Latest updates to the Dasiglucagon Clinical Trial in Congenital Hyperinsulinism page
- Check3 days agoChange DetectedThe revision history now shows a new entry for v3.4.1 and removes the previous v3.4.0 entry.SummaryDifference0.1%

- Check10 days agoChange DetectedThe page now shows the glossary toggle and color-coded change indicators (green for additions, red for deletions). It also updates to Revision: v3.4.0 and removes older entries like No FEAR Act data and Revision: v3.3.4.SummaryDifference0.8%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe history list now shows Revision: v3.3.4 added and Revision: v3.3.3 removed, reflecting a minor update to the page's revision history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision: v3.3.3 was added; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check74 days agoChange DetectedThe page shows an updated revision tag from v3.2.0 to v3.3.2, a minor UI/versioning change with no impact on study data or functionality.SummaryDifference0.1%

- Check81 days agoChange DetectedThe government funding lapse notice banner on the page header was removed. The study history and record content remain unchanged.SummaryDifference0.6%

Stay in the know with updates to Dasiglucagon Clinical Trial in Congenital Hyperinsulinism
Enter your email address, and we'll notify you when there's something new on the Dasiglucagon Clinical Trial in Congenital Hyperinsulinism page.